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189Exercise Testing in Asymptomatic Severe Aortic StenosisThe management and the clinical decision making in asymptomatic patients with aortic stenosis are challenging.
An “aggressive” management, including early aortic valve replacement, is debated in these patients. However, the
optimal timing for surgery remains controversial due to the lack of prospective data on the determinants of aortic
stenosis progression, multicenter studies on risk stratiﬁcation, and randomized studies on patient management.
Exercise stress testing with or without imaging is strictly contraindicated in symptomatic patients with severe
aortic stenosis. Exercise stress test is now recommended by current guidelines in asymptomatic patients and
may provide incremental prognostic value. Indeed, the development of symptoms during exercise or an
abnormal blood pressure response are associated with poor outcome and should be considered as an
indication for surgery, as suggested by the most recently updated European Society of Cardiology 2012
guidelines. Exercise stress echocardiography may also improve the risk stratiﬁcation and identify asymptomatic
patients at higher risk of a cardiac event. When the test is combined with imaging, echocardiography during
exercise should be recommended rather than post-exercise echocardiography. During exercise, an increase
>18 to 20 mm Hg in mean pressure gradient, absence of improvement in left ventricular ejection fraction (i.e.,
absence of contractile reserve), and/or a systolic pulmonary arterial pressure >60 mm Hg (i.e., exercise
pulmonary hypertension) are suggestive signs of advanced stages of the disease and impaired prognosis.
Hence, exercise stress test may identify resting asymptomatic patients who develop exercise abnormalities and
in whom surgery is recommended according to current guidelines. Exercise stress echocardiography may
further unmask a subset of asymptomatic patients (i.e., without exercise stress test abnormalities) who are at
high risk of reduced cardiac event free survival. In these patients, early surgery could be beneﬁcial, whereas
regular follow-up seems more appropriate in patients without echocardiographic abnormalities during
exercise. (J Am Coll Cardiol Img 2014;7:188–99) ª 2014 by the American College of Cardiology FoundationAortic stenosis (AS) is the most common valvular
disease and the third most prevalent form of car-
diovascular disease in the Western world. Its
prevalence increases with population aging and is
present in 3% to 7% of patients over 65 years of
age (1). The diagnosis of AS is classically based on
echocardiography and may be supplemented by
other cardiovascular imaging modalities. The ma-
jority of AS patients are asymptomatic but have an
increased risk of untoward events such as ventric-
ular dysfunction, symptomatic deterioration, heart
failure, and even death in a signiﬁcant proportion
of them. In 2 recent studies including asymptom-
atic patients with at least moderate AS, a mean rate
of cardiovascular death and of sudden death of
3.7% and 1.55% respectively, were reported during
a median follow-up of 16 to 18 months (2,3). In
this regard, “aggressive” management, including
early aortic valve replacement (AVR), is debated in
asymptomatic patients. The optimal timing for
AVR remains controversial due to the lack of
prospective data on the determinants of AS pro-
gression, multicenter studies on risk stratiﬁcation,
and randomized studies on patient management. Inthe recently updated European Society of Cardi-
ology (ESC) guidelines and in the current Amer-
ican College of Cardiology/American Heart
Association (ACC/AHA) guidelines (4), based on
a consensus of experts, the only class I indication
for performing an AVR in patients with severe AS
is the presence of symptoms at rest or during an
exercise test and/or the presence of left ventricular
(LV) systolic dysfunction, deﬁned as LV ejection
fraction <50%. Initial symptoms experienced by
patients with AS are often subtle or insidious and
can be difﬁcult to identify purely on clinical
grounds. Many patients either fail to acknowledge
their symptoms or do not report their symptoms
promptly. The development of symptoms signiﬁes
a dramatic change in the natural history of the
condition with a reported average survival of <2
years. Moreover, patients who become symptom-
atic are at signiﬁcant risk of developing adverse
cardiac events while waiting for surgery, and peri-
operative risk increases signiﬁcantly with the
severity of symptoms. Of note, women seem to be
less likely than men to be referred for surgery
despite symptoms and severe AS. This adverse
A B B R E V I A T I O N S
A N D A C R O N YM S
ACC/AHA = American
College of Cardiology/
American Heart
Association
AS = aortic stenosis
AVR = aortic valve
replacement
ESC = European Society of
Cardiology
LV = left ventricular
PHT = pulmonary
hypertension
SPAP = systolic
pulmonary arterial
pressure
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190clinical outcome has recently raised the question of
whether performing early elective surgery could be
a more beneﬁcial strategy in reducing long-term
risk. However, there is reluctance to perform sur-
gery earlier than necessary because of a mortality
rate for AVR of approximately up to 3% to 5%,
even in patients younger than 70 years of age,
followed by long-term prosthetic valve-related
morbidity.
The ESC and the ACC/AHA have placed
renewed emphasis on the role of exercise testing to
provide objective evidence of exercise capacity and
symptom status in patients with valvular heart dis-
ease (4,5). Exercise testing represents the ﬁrst choice
over pharmacological stress for risk stratiﬁcation in
asymptomatic patients with AS (6,7). When
combined with echocardiography, although post-
exercise echocardiography using treadmill or bicy-cle exercise may be used, supine bicycle
exercise is the recommended technique.
Semisupine exercise echocardiography offers
the advantage that Doppler information, in
addition to the assessment of regional wall
motion, can be evaluated at peak exercise but
also continuously throughout the test (8).
However, exercise test is strictly contra-
indicated in symptomatic patients with AS.
Indications for Exercise Stress Test
AS is a prevalent condition and a progressive
disease (2). When symptoms appear, usually
after a long asymptomatic period, prompt
surgical replacement of the aortic valve is
warranted (4,9). The risk of sudden death is
usually considered as low in asymptomaticpatients, even with severe AS. It may, nevertheless,
occur soon after the onset of symptoms or if the
waiting period for surgery is too long. Moreover,
symptomatic status can be difﬁcult to establish,
especially in elderly patients, who may ignore their
symptoms or may reduce their level of physical
activity to avoid or minimize symptoms. Thus,
exercise testing could be useful to unmask symp-
toms in patients with severe AS who claim to be
asymptomatic or who have equivocal symptoms. A
recent meta-analysis conﬁrmed that symptom-
limited stress testing is safe and has an impor-
tant prognostic value (10). Of interest, among the
7 studies comprising approximately 500 patients,
none of the patients with normal exercise stress
test experienced sudden cardiac death. Exercise
testing is strongly advocated in the ESC guidelines
(5), whereas it is a Class IIb recommendation inthe ACC/AHA guidelines (4). In asymptomatic
AS, the clinical value of exercise echocardiography
as well as its place in the recent guidelines is still
limited. It may, however, reﬁne the risk stratiﬁ-
cation of asymptomatic AS patients. In this re-
gard, exercise stress test could be recommended in
patients with at least moderate AS in which
symptom status is unclear. Furthermore, exercise
stress echocardiography could be helpful for the
management of patients with asymptomatic mod-
erate to severe AS and preserved LV function.
Recommended Exercise Protocol
The following section is mainly based on our
experience. These recommendations arise from
more than 10 years of practice and from confron-
tation and discussion with other groups in Europe
and North America.
A symptom-limited graded exercise test is rec-
ommended, and at least 80% of the age-predicted
heart rate should be reached in the absence of
symptoms. The test should be adapted to the clin-
ical condition and should be performed under
supervision of experienced person.
When the test is not combined with imaging,
treadmill exercise is the most commonly used test in
the United Kingdom and in the United States,
while the upright bicycle test is the preferred
approach in the rest of Europe. The exercise stress
test is performed according the ACC/AHA practice
guidelines using a Bruce modiﬁed protocol (11). In
contrast, when combined with imaging during ex-
ercise, the test is performed on a dedicated tilted
bicycle (Fig. 1).
Classically, the initial workload of 25 W is
maintained for 2 min and the workload is increased
every 2 min by 25 W. An increase by 10 W seems
to be more appropriate in elderly patients with AS
or in patients with low level of physical activities.
Blood pressure and a 12-lead electrocardiogram are
recorded at rest and at each step of the test. The
patient should be frequently questioned for symp-
toms. Exercise test is interrupted promptly when
the target heart rate is reached or in case of typical
chest pain, limiting breathlessness, dizziness,
muscular exhaustion, hypotension (drop in systolic
blood pressure $20 mm Hg), or signiﬁcant ven-
tricular arrhythmias. To note, isolated abnormal-
ities in the ST-segment (>2 mm ST-segment
depression, horizontal, or down-sloping) are rarely
a reason to stop the stress examination in patients
with AS. The test is considered abnormal if the
patient presents with $1 of the following criteria:
Figure 1. Exercise Stress Echocardiography Laboratory
Example of setting currently used to performed exercise stress echocardiog-
raphy including 12-lead electrocardiogram and sphygmomanometer.
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191angina, evidence of dyspnea, dizziness, syncope or
near-syncope, $2 mm ST-segment depression in
comparison to baseline level, fall in systolic blood
pressure $20 mm Hg or below baseline value,
and complex ventricular arrhythmias (ventricular
tachycardia, more than 3 premature ventricular
complexes in a row) (12). The following contra-
indications should be strictly respected: 1) truly
symptomatic AS (exertional shortness of breath,
angina, dizziness, or syncope); 2) physical or
mental disability to adequately perform an exercise
stress test; 3) clear indication for surgery; 4) high
blood pressure (systolic arterial pressure >200 mm Hg
or diastolic arterial pressure >110 mm Hg);
5) uncontrolled or symptomatic arrhythmias; and
6) systemic illness.
Exercise Echocardiography
Exercise echocardiography (i.e., imaging performed
during exercise) requires training and experience
and the use of an adequate stress table. The images
acquisition will focus on parameters related to the
valve (including hemodynamics), to the LV and to
the systolic pulmonary arterial pressure (SPAP). As
some valve-related exercise changes are evanescent,
peak exercise imaging is mandatory. Change in the
LV ﬁlling pressure estimation (i.e., E/e0 ratio)
should be obtained at low level of exercise (usually
around 100 beats/min) in order to avoid E and A
waves fusion and to ensure good tissue Doppler
imaging quality; all other parameters should be
obtained throughout the test. The dynamic changes
in aortic mean pressure gradient and in trans-
tricuspid pressure gradient need to be assessed
throughout the test, from rest to low, intermediate,
and peak levels of exercise (13,14). Due to frequent
LV and aortic valve biphasic hemodynamic and
mechanical responses during exercise, the imaging
acquisition throughout the test may help to unmask
this phenomenon (15). A rapid increase in pressure
gradients or in SPAP can indicate a more severe
disease process or an absence of pulmonary vascular
function adaptation, low pulmonary compliance,
and markedly increased pulmonary resistance.
The assessment of exercise-induced changes in
LV systolic function is also very useful. Worsening
in wall motion from baseline classically indicates an
ischemic insult. The use of wall motion score may
help to quantify such abnormalities that do not
necessarily indicate the presence of signiﬁcant
coronary artery disease. The absence of LV con-
tractile reserve is generally characterized by the
absence or only small increase in LV ejectionfraction or in long-axis function (derived from
tissue Doppler imaging or 2-dimensional [2D]
speckle tracking) (12,15–17). In a series of 50
asymptomatic patients with AS and normal resting
LV ejection fraction (>50%), 40% of patients did
not have LV contractile reserve and showed a
signiﬁcant exercise-induced decrease in LV ejection
fraction (from 64  10% to 53  12%), suggesting
that around one-half of them exhibited overt LV
dysfunction during exercise. Furthermore, these
patients with abnormal LV function adaptation
during exercise more frequently developed symp-
toms during exercise and had lower event-free
survival (18).
Recently, Donal et al. (17) reported that the
quantiﬁcation of LV myocardial longitudinal
function using 2D speckle tracking during sub-
maximal exercise may identify subclinical LV
dysfunction. In addition, compared with LV ejec-
tion fraction, exercise LV longitudinal function
appears to more accurately detect early and latent
LV dysfunction, and an improvement <–1.4% in
LV global longitudinal strain has been shown to be
associated with a high risk of exercise abnormal
response (17).Clinical and Prognostic Value of Exercise Test
There are more studies published in the literature
promoting the use of exercise stress test (i.e.,
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192without imaging) than supporting exercise stress
echocardiography.
Changes in clinical and electrocardiographic pa-
rameters during treadmill exercise test have been
recently proven to inﬂuence the prognosis and
subsequent clinical decision making in asymptom-
atic AS patients (Table 1). Approximately one-third
of patients who claim to be asymptomatic may
develop symptoms on exercise (14,18–22). The
occurrence of exercise-limiting symptoms (dizzi-
ness, dyspnea at low workload, angina, or syncope),
although nonspeciﬁc, predicts the rapid develop-
ment of symptoms in daily life, cardiac death
(including sudden death) and need for AVR (19–22),
particularly in patients who are<70 years of age and
physically active (21). Dizziness during a treadmill
test had a higher positive predictive value than other
criteria for the development of symptoms during the
next year (21). The occurrence of rapidly reversible
dyspnea at high workload (close to the age-sex
predicted maximum workload) is considered to be
normal. Abnormal blood pressure response
(<20 mm Hg increase in systolic blood pressure)
and ST-segment depression (>2 mm, horizontal or
down-sloping) during exercise do not seem to
improve the accuracy of the test (21).
In the meta-analysis published by Raﬁque et al.
(10), it was shown that an abnormal exercise testTable 1. Impact of Exercise Testing on Outcome and Clinical Decisi
Stress Data Parameters Impact on Outco
Clinical
Symptoms (dizziness,
dyspnea at low
workload, angina,
syncope)
Onset of symptom
cardiac-related d
AVR dictated by
symptomsAbnormal blood
pressure response (fall
in blood pressure)
Electrocardiographic Ventricular arrhythmias
ST-segment
depression
($2 mm)
Onset of symptom
cardiac-related d
AVR dictated by
symptoms
Echocardiographic Increase in mean aortic
pressure gradient:
>18 or 20 mm Hg
Spontaneous symp
cardiac-related d
AVR dictated by
symptoms,
hospitalization fo
heart failure
Decrease/small increase
in LV ejection fraction
Spontaneous symp
cardiac-related d
abnormal exercis
test
Exercise PHT Reduced cardiac ev
free survival, hig
of cardiac death
ACC/AHA ¼ American College of Cardiology/American Heart Association; AS ¼ aortic
LV ¼ left ventricular; PHT ¼ pulmonary arterial hypertension.in asymptomatic patients with AS leads to an 8-fold
increase in risk of cardiac event during the follow-
up. More importantly, the risk of sudden death
was increased 5.5-fold.
During exercise stress test, appraisal of the respi-
ratory gas-exchange and the measurement of peak
maximal oxygen uptake (VO2) may be of interest. In
a recent bicentric study, we have shown that
asymptomatic patients with AS might have reduced
maximal exercise capacity, even in the absence of
LV dysfunction or abnormal exercise response (in
terms of symptoms, blood pressure, or electric
changes) (23). Indeed, close to one-half of our pa-
tients had markedly reduced (<84%) age- and
sex-predicted peak VO2, according to the American
Thoracic Society/American College of Chest Phy-
sicians recommendations (24). Furthermore, the
main determinant of impaired maximal exercise ca-
pacity was elevated global LV hemodynamic after-
load (i.e., valvuloarterial compliance, a surrogate of
both valvular and arterial overload burden faced by
the LV). Consequently, the measurement of peak
VO2 may provide an objective parameter allowing
a better assessment of the symptomatic status and
unmasking patients who deny symptoms or adapt
their life-style to their condition. In the follow-up of
these patients, regular (yearly) maximal exercise ca-
pacity evaluation could be of clinical interest and mayon Making in Patients With Asymptomatic AS
me Ref. #
Impact on Clinical Decision (AVR)
ESC Guidelines ACC/AHA Guidelines
s,
eath,
(19,21,45)
Class I (level
of evidence: C)
Class IIb (level
of evidence: C)
Class IIa (level
of evidence: C)
Class IIb (level
of evidence: C)
s,
eath,
(19,21,45) d Class IIb (level
of evidence: C)
toms,
eath,
r
(14,22) Class IIb (level
of evidence: C)
d
toms,
eath,
e
(18) d d
ent-
h rate
(13) d d
stenosis; AVR ¼ aortic valve replacement; ESC ¼ European Society of Cardiology;
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193improve the timing of surgery. Nonetheless, the
relationship between decreased maximal exercise
capacity in asymptomatic AS patients and outcome
requires clariﬁcation and further studies.
Clinical and Prognostic Value of
Exercise Echocardiography
Exercise-induced changes in mean pressure
gradient. In asymptomatic moderate or severe AS
(valve area <1.2 cm2), exercise-induced changes in
LV function or AS indexes are predictive of the
outcome. Whatever the results of the exercise test,
an increase in mean aortic pressure gradient by $18
to 20 mm Hg during exercise (Fig. 2) is associated
with an increased risk of cardiac-related events
(14,22). Two studies have reported similar results
regarding the prognostic value of exercise-induced
changes in mean aortic pressure gradient in
asymptomatic AS. Our group has reported the re-
sults of a series including 69 consecutive patients
with asymptomatic severe AS and normal LV
function in whom exercise stress echocardiography
was performed. Although patients who experiencedFigure 2. Example of an Asymptomatic Patient With Severe Aortic
Despite Only Mild Increase in LV Stroke Volume
bpm ¼ beats per minute; HR ¼ heart rate; LV ¼ left ventricular; LVOT ¼
VTI ¼ velocity-time integral.an event during the follow-up had no signiﬁcant
difference in mean aortic pressure gradient at rest,
as compared to those without event (41 12 mmHg
vs. 38  9 mm Hg), they exhibited a signiﬁcant
higher exercise-induced increase in mean gradient
(þ23  8 mm Hg vs. þ12  7 mm Hg). Conse-
quently, patients with marked exercise-induced
increase in mean aortic pressure gradient also
have signiﬁcantly worse cardiac event-free survival
(around 80% of events at 2-year follow-up).
Furthermore, this parameter seems to provide in-
cremental prognostic value over resting echocar-
diographic data and exercise electrocardiogram (22).
In 2010, a multicenter study conﬁrmed our re-
sults (14). They have reported the resting and
exercise echocardiographic data of 186 “truly”
asymptomatic patients (i.e., without abnormality
during an exercise test) with at least moderate AS.
The cutoff value of an exercise-induced increase in
mean aortic pressure gradient >þ20 mm Hg was
identiﬁed as a powerful predictor of poor outcome
and was independently associated with a 3.8-fold
increase in risk of cardiac event, regardless of age,
exercise LV ejection fraction, or resting mean aorticStenosis and Exercise-Induced Increase in MPG,
left ventricular outﬂow tract; MPG ¼ mean aortic pressure gradient;
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194pressure gradient. Interestingly, these 2 studies
reported a rate of marked (i.e., >18 to 20 mm Hg)
increase in mean gradient during exercise of 35%
and 21%, respectively.
The increase in pressure gradient reﬂects the
presence of either a more severe AS (the more severe
the stenosis at rest, the higher the increase in
gradient for a given ﬂow rate during exercise) and/or
a noncompliant and rigid aortic valve (no or mini-
mal improvement of aortic valve oriﬁce area during
test) (25). The latter phenomenon could be related
to the presence of highly calciﬁed aortic valve, which
is, in turn, considered as an important marker of
outcome (26–28).
The exercise-induced changes in aortic mean
pressure gradient should, however, be analyzed in
the light of the exercise-induced changes in LV
stroke volume. Indeed, a marked increase in LV
stroke volume in response to exercise may directly
affect the aortic mean pressure gradient, even in
the presence of aortic valve opening reserve. In
contrast, in highly calciﬁed aortic stenosis, without
improvement in aortic valve area during exercise,
mild increase in LV stroke volume may produce
signiﬁcant changes in mean aortic pressure gradient.
Exercise-induced changes in LV function and
contractile reserve. The assessment of the adapta-
tion of LV function during exercise is of clinical in-
terest. Patients with a decrease or a small increase in
LV ejection fraction during exercise are more likely
to exhibit an abnormal response to exercise and
cardiac-related events during follow-up (17,18). In
the study by Marechaux et al. (18), LV contractile
reserve was deﬁned as an exercise-induced increase in
LV ejection fraction, and its absence was associated
with more frequent abnormalities and development
of symptoms during exercise (Fig. 3) and with
markedly reduced midterm cardiac event-free sur-
vival (around 40% at 2-year follow-up). Further-
more, abnormal response to exercise (i.e., excessive
symptoms, fall or <20 mm Hg increase in systolic
blood pressure, and$2mmST-segment depression)
was associated with a maladaptation of the LV
ejection fraction during exercise (decrease or only
mild increase) (12). Using tissue Doppler imaging,
Van Pelt et al. (29) suggested that an exercise-
induced increase in S0-wave velocity >5 cm/s could
be a good cutoff value to determine the presence of
LV contractile reserve. Similarly, 2D speckle
tracking analysis was used by Donal et al. (17), who
report a threshold of –1.4% in exercise-induced
changes in LV global longitudinal strain as accurate
marker of LV contractile reserve. Nonetheless, it
should be noted that these studies are based onrelatively small sample sizes and did not validate their
cutoff values against patients’ outcome.
During exercise, the increase in LV stroke vol-
ume, cardiac output, and cardiac index is manda-
tory to adequately respond to the peripheral
demands. In the absence of substantial increase in
systolic blood pressure, the peripheral demands
may rapidly exceed the rise in cardiac output. This
phenomenon may explain, at least in part, the oc-
currence of symptoms, such as chest pain, angina
pectoris, or leg discomfort (25,30,31). Similarly,
reduced LV compliance and relaxation may par-
ticipate in the increase in LV ﬁlling pressure (E/e0
ratio), which also contributes to limited exercise
capacity and symptoms (mainly dyspnea) in pa-
tients with severe AS (32). Furthermore, using
2D speckle tracking echocardiography, the assess-
ment of myocardial longitudinal function with the
quantiﬁcation of global longitudinal strain may
identify subtle, latent, and early LV dysfunction in
asymptomatic patients with preserved LV ejection
fraction (Fig. 3).
Exercise-induced changes in SPAP. Elevated SPAP
and the presence of pulmonary hypertension
(PHT) (SPAP >50 mm Hg in patients with
severe AS) (Fig. 4) seem to be associated with a
poor prognosis (33,34) and a higher mortality rate
after valve replacement (35), and they represent an
independent predictor of hospital mortality and
post-operative major adverse cardiovascular and
cerebrovascular events (36). In patients receiving
transcatheter aortic valve implantation, PHT was a
strong independent predictor of poor outcome,
doubling the risk of late mortality (37). However,
when present, PHT is often associated with symp-
toms, which limits its usefulness for clinical decision
making. In contrast, exercise PHT is generally
considered as a predictor of occurrence of resting
PHT during the follow-up, development of symp-
toms, and/or outcome in various cardiac diseases
(38–40), including valvular heart disease (41–43).
We have reported the prospective results of 105
“truly” asymptomatic patients with severe AS in
whom exercise echocardiography was performed
purposely to identify the changes in SPAP during
exercise. Whereas only 6% of the population
exhibited resting PHT (SPAP >50 mm Hg), 55%
of patients developed exercise PHT (SPAP >60
mm Hg). Exercise PHT was mainly determined by
resting SPAP and male sex, but also by exercise
parameters of diastolic dysfunction burden (exercise
indexed LV end-diastolic volume, exercise e0-wave
velocity and exercise-induced changes in indexed
left atrial area). Moreover, exercise PHT was
Figure 3. Example of the Presence of LV Contractile Reserve in an Asymptomatic Patient With Severe Aortic Stenosis Using LVEF
and GLS (Using 2D Speckle Tracking)
(A) Shows an apical 2-dimensionnal (2D) 4-chamber view and (B) shows measurement of left ventricular (LV) myocardial longitudinal strain.
ANT ¼ anterior; GLS ¼ global longitudinal strain; INF ¼ inferior; LAT ¼ lateral; LVEF ¼ left ventricular ejection fraction; POST ¼ posterior;
SEPT ¼ septal.
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195independently associated with a 2-fold increase in
risk of cardiac event at 3-year follow-up. Interest-
ingly, 7 cardiovascular deaths (3 sudden deaths and
4 deaths following heart failure requiringhospitalization) were reported in this series, and all
of these fatal events occurred in the group of pa-
tients with exercise PHT, whereas only 1 patient
died who had resting PHT.
Figure 4. Example of Development of Exercise Pulmonary Hypertension (Systolic Pulmonary Arterial Pressure >60 mm Hg) in an
Asymptomatic Patient With Aortic Stenosis
Red lines refer to Doppler envelope and asterisks to the peak measurements of waves. MPG ¼ mean aortic pressure gradient;
TTPG ¼ transtricuspid pressure gradient.
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196Practically, the measurement of SPAP through-
out the exercise could provide useful additive in-
formation. However, the dynamic changes in SPAP
and the occurrence of exercise PHT should be
cautiously interpreted and analyzed in light of age,
exercise load, and changes in systemic blood pres-
sure and in cardiac output.
Impact on Clinical Decision Making
In the most recent ESC guidelines, AVR is now
indicated in asymptomatic severe AS, if the exercise
test is abnormal, particularly in case of symptom
development (Class I, Level of Evidence: C) orasymptomatic hypotension (Class IIa, Level of
Evidence: C) (5). Conversely, ACC/AHA 2006
guidelines only recommend performing AVR as
Class IIb in patients with severe AS and equivocal
symptoms depicting exercise-induced symptoms or
fall in blood pressure (4). Consequently, regarding
the most recent expert consensus, it seems
reasonable to perform AVR in asymptomatic severe
AS patients with preserved LV function but in the
presence of exercise abnormalities. Actually, these
recommendations emphasize that such abnormal-
ities may identify asymptomatic patients in whom
AVR could be beneﬁcial. Nevertheless, in patients
without exercise abnormalities, exercise stress
Figure 5. Decisional Algorithm for the Management of Asymptomatic Patients With Preserved LV Ejection Fraction (>50%)
AS ¼ aortic stenosis; ECG ¼ electrocardiogram; FU ¼ follow-up; LV ¼ left ventricular; MPG ¼ mean aortic pressure gradient; PHT ¼ pulmonary
hypertension; SBP ¼ systolic blood pressure; VO2 ¼ maximal oxygen uptake.
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197echocardiography may be very useful. Indeed, in
the light of our experience, patients with incon-
clusive or negative exercise test but with comor-
bidities and patients over 65 to 70 years of age may
have some hemodynamic or LV function alter-
ations that can be revealed by a comprehensive
exercise echocardiographic test (Fig. 5). As under-
lined previously, exercise-induced changes in mean
aortic pressure gradient, LV ejection fraction, LV
longitudinal strain, and SPAP may identify a subset
of patients with early and subtle, sometimes latent,
harmful consequences of the increased LV afterload
generated by the AS. The current ESC guidelines
indicate that AVR may be considered in asymp-
tomatic patients with severe AS, normal LV ejection
fraction, and increase of mean pressure gradient
during exercise by >20 mm Hg (Class IIb, Level of
Evidence: C). In addition, and despite no clear
recommendations, the ESC guidelines state that
exercise stress echocardiography may provide
prognostic information in asymptomatic severe AS
by assessing the changes in LV function. In addi-
tion to these recommendations and in light of our
experience, it appears that elevated exercise SPAP
and the presence of exercise PHT may be consid-
ered as a trigger for surgery in asymptomaticpatients, mainly due to the unexpected high rate of
cardiac event and death reported in these patients
(13). Indeed, early surgery could be beneﬁcial in
these patients. At least, referral to dedicated
valvular heart disease clinic (44) and close follow-
up (3- to 6-month follow-up) could be indicated.
At the time of the visit, careful evaluation of
symptoms is mandatory. The measurement of peak
VO2 could be promoted to objectivize the symp-
tomatic status, and the visit may be completed by
exercise stress echocardiography.
On the other hand, patients with appropriate
exercise echocardiographic adaptation (i.e., increase
in mean aortic pressure gradient <18 to 20 mm Hg,
increase in LV ejection fraction, absence of exercise
PHT) may be safely followed up every year.
Obviously, conﬁrmatory data are needed to sup-
port incorporating this technique in the daily
management of asymptomatic patients with AS.
Conclusions
In asymptomatic patients with severe AS, exercise
stress test and exercise stress echocardiography may
provide incremental clinical and prognostic value, in
addition to physical examination and resting
Magne et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 2 , 2 0 1 4
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198echocardiography. Exercise stress test may identify
resting asymptomatic patients who develop exercise
abnormalities and in whom surgery may be recom-
mended according to current guidelines. Exercise
stress echocardiography may further unmask a
subset of asymptomatic patients (i.e., without ex-
ercise stress test abnormalities) who are at high risk
of reduced cardiac event free survival. In thesepatients, early surgery may be beneﬁcial, whereas
regular follow-up seems more appropriate in pa-
tients without echocardiographic abnormalities
during exercise.
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